Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What is the best method of detecting atrial fibrillation in people aged 65 years and older?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Fuster V et al. (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for Management of Patients with Atrial Fibrillation). J Am Coll Cardiol 48: 854–906

    Article  Google Scholar 

  2. Mant J et al. for the BAFTA Investigators and the Midland Research Practices Network (MidReC) (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370: 493–503

    Article  CAS  Google Scholar 

  3. Hylek EM et al. (2007) Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115: 2689–2696

    Article  CAS  Google Scholar 

  4. Glotzer TV et al. (2006) Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study. J Interv Card Electrophysiol 15: 9–14

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

DG Wyse has acted as a Consultant for Astellas Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, CV Therapeutics, Medtronic, Novartis, Sanofi-Aventis, and Transoma Medical.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wyse, D. What is the best method of detecting atrial fibrillation in people aged 65 years and older?. Nat Rev Cardiol 5, 138–139 (2008). https://doi.org/10.1038/ncpcardio1063

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1063

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing